NL-OMON55430招募中不适用
Autologous hematopoietic stem cell gene therapy in RAG-deficient severe combined immunodeficiency: pre-phase study - RAG gene therapy pre-phase
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Selection as stem cell donor for a family member;
- •- In case of stem cells from mobilized peripheral blood: completion of G-CSF
- •mobilization procedure for collection of CD34+ HSC from G-CSF mobilized
- •peripheral blood;
- •Age > 18 years;
- •Able to comprehend and give signed informed consent.
排除标准
- •Any condition precluding stem cell donation
研究者
相似试验
招募中
2 期
Autologous Stem Cell Transplant in Multiple SclerosisNeurological - Multiple sclerosisMultiple SclerosisACTRN12622000536763St Vincent's Hospital, Sydney30
进行中（未招募）
1 期
Randomized study with stem cell transplantation versus standard treatment with alemtuzumab, cladribine or ocrelizumab in patients with relapsing remitting multiple sclerosis.EUCTR2017-001362-25-SEHelse Bergen HF, Haukeland University Hospital100
进行中（未招募）
1 期
Randomized study with stem cell transplantation versus standard treatment with alemtuzumab, cladribine or ocrelizumab in patients with relapsing remitting multiple sclerosis.Relapsing remitting multiple sclerosis.MedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-001362-25-NLHelse Bergen HF, Haukeland University Hospital100
进行中（未招募）
1 期
Randomized study with stem cell transplantation versus standard treatment with alemtuzumab, cladribine or ocrelizumab in patients with relapsing remitting multiple sclerosis.Relapsing remitting multiple sclerosis.MedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-001362-25-DKHelse Bergen HF, Haukeland University Hospital100
已完成
不适用
autologous hematopoietic stem cell transplantation followed by reduced intensity allogeneic stem cell transplantation for relatively young patients with multiple myelomamultiple myelomaJPRN-UMIN000002533The university of Tokyo Hospital,department of hematology and oncology20